Contact this trialFirst, we need to learn more about you.
Small Molecule Inhibitor
NEU-411 for Parkinson's Disease
Recruiting0 awardsPhase 2
Farmington Hills, Michigan
This trial aims to study the effectiveness and safety of NEU-411 in men and women aged 50-80 with early Parkinson's Disease who have specific genetic characteristics related to the LRRK2
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service